(Q39657661)

13 September 2017

1 reference

title

Endocrine approaches to male fertility control (English)

1 reference

13 September 2017

U A Knuth

1

1 reference

13 September 2017

E Nieschlag

series ordinal

2

1 reference

13 September 2017

publication date

1 February 1987

1 reference

Bailliere's clinical endocrinology and metabolism

13 September 2017

published in

1 reference

13 September 2017

volume

1

1 reference

13 September 2017

issue

1

1 reference

13 September 2017

page(s)

113-131

1 reference

Pituitary and testicular functions in sexually mature rhesus monkeys under high-dose LRH-agonist treatment

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980055-1

7 January 2021

Reversible induction of azoospermia in rhesus monkeys by constant infusion of a gonadotropin-releasing hormone agonist using osmotic minipumps

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980055-1

7 January 2021

Testosterone supplementation attenuates the antifertility effects of an LHRH agonist in male rhesus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980055-1

7 January 2021

Acute and chronic effects of a gonadotrophin-releasing hormone antagonist on pituitary and testicular function in monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980055-1

7 January 2021

Pregnancies associated with sperm concentrations below 10 million/ml in clinical studies of a potential male contraceptive method, monthly depot medroxyprogesterone acetate and testosterone esters

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980055-1

7 January 2021

Hypophysial Responses to Continuous and Intermittent Delivery of Hypothalamic Gonadotropin-Releasing Hormone

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980055-1

7 January 2021

Pharmacokinetics of 19-nortestosterone esters in normal men.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980055-1

7 January 2021

Mechanisms of gonadotropin-releasing hormone agonist action in the human male

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980055-1

7 January 2021

Hormonal effects of gonadotropin-releasing hormone (GnRH) agonist in the human male. III. Effects of long term combined treatment with GnRH agonist and androgen

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980055-1

7 January 2021

Does constant infusion of gonadotropin-releasing hormone agonist lead to greater suppression of gonadal function in man than its intermittent administration?

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980055-1

7 January 2021

Absence of gonadotropin-releasing hormone receptors in human gonadal tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980055-1

7 January 2021

Androgenisation of female partners of men on medroxyprogesterone acetate/percutaneous testosterone contraception

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980055-1

7 January 2021

Combined treatment with an LHRH agonist and testosterone in man. Reversible oligozoospermia without impotence

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980055-1

7 January 2021

Gonadotropin and steroid secretory patterns during chronic treatment with a luteinizing hormone-releasing hormone agonist analog in men.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980055-1

7 January 2021

A luteinizing hormone-releasing hormone agonist decreases biological activity and modifies chromatographic behavior of luteinizing hormone in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980055-1

7 January 2021

The effects of low doses of cyproterone acetate on some functions of the reproductive system in normal men

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980055-1

7 January 2021

The Stimulatory and Down-Regulatory Effects of a Gonadotropin-Releasing Hormone Agonist in Man*

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980055-1

7 January 2021

Improvement in spermatogenesis following depression of human testis with testosterone

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980055-1

7 January 2021

Gonadotropin-releasing hormone analog design. Structure-function studies toward the development of agonists and antagonists: rationale and perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980055-1

7 January 2021

Clinical trial of 19-nortestosterone-hexoxyphenylpropionate (Anadur) for male fertility regulation

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980055-1

7 January 2021

Treatment of prostate cancer with gonadotropin-releasing hormone agonists

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980055-1

7 January 2021

Reversible inhibition of testicular steroidogenesis and spermatogenesis by a potent gonadotropin-releasing hormone agonist in normal men: an approach toward the development of a male contraceptive

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980055-1

7 January 2021

Influence of Continuous Gonadotropin-Releasing Hormone (GnRH) Agonist Treatment on Luteinizing Hormone and Testosterone Secretion, the Response to GnRH, and the Testicular Response to Human Chorionic Gonadotropin in Male Rhesus Monkeys*

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980055-1

7 January 2021

Stimulation of spermatogenesis in stalk-sectioned rhesus monkeys by testosterone alone

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980055-1

7 January 2021

Testosterone can initiate spermatogenesis in an immature nonhuman primate, Macaca fascicularis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980055-1

7 January 2021

Structure of the porcine LH- and FSH-releasing hormone. I. The proposed amino acid sequence

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980055-1

7 January 2021

Investigations on the use of testosterone oenanthate as a male contraceptive agent.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980055-1

7 January 2021

Demonstration of the Reversibility of Spermatozoa Suppression by Testosterone Oenanthate

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980055-1

7 January 2021

Failure of high-dose sustained release luteinizing hormone releasing hormone agonist (buserelin) plus oral testosterone to suppress male fertility

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980055-1

7 January 2021

Medium dose cyproterone acetate (CPA): effects on hormone secretion and on spermatogenesis in men.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980055-1

7 January 2021

Clinical trial with testosterone undecanoate for male fertility control

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980055-1

7 January 2021

Heterogeneity of sperm density profiles following 20-week therapy with high-dose LHRH analog plus testosterone

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980055-1

7 January 2021

Reversible antifertility action of testosterone propionate in human males

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980055-1

7 January 2021

Effects of chronic treatment with a potent luteinizing hormone releasing hormone agonist on serum luteinizing hormone and steroid levels in the male rhesus monkey

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980055-1

7 January 2021

Relative binding affinity of anabolic-androgenic steroids: comparison of the binding to the androgen receptors in skeletal muscle and in prostate, as well as to sex hormone-binding globulin

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980055-1

7 January 2021

Absence of a direct inhibitory effect of the gonadotropin-releasing hormone (GnRH) agonist D-Ser (TBU)6, des-Gly-NH2(10) GnRH ethylamide (Buserelin) on testicular steroidogenesis in men

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980055-1

7 January 2021

Comparison of testosterone, dihydrotestosterone, luteinizing hormone, and follicle-stimulating hormone in serum after injection of testosterone enanthate of testosterone cypionate

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980055-1

7 January 2021

Comparative pharmacokinetics of testosterone enanthate and testosterone cyclohexanecarboxylate as assessed by serum and salivary testosterone levels in normal men

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980055-1

7 January 2021

Saliva and serum testosterone following oral testosterone undecanoate administration in normal and hypogonadal men

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980055-1

7 January 2021

Reversible azoospermia induced by the anabolic steroid 19-nortestosterone

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980055-1

7 January 2021

Suppression of pituitary and testicular function in normal men by constant gonadotropin-releasing hormone agonist infusion

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980055-1

7 January 2021

Reversible inhibition of sperm production and gonadotrophin secretion in men following combined oral medroxyprogesterone acetate and percutaneous testosterone treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980055-1

7 January 2021

Active immunization with follicle-stimulating hormone for fertility control: a 4 1/2-year study in male rhesus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980055-1

7 January 2021

Inhibition of pituitary-testicular function with [D-Trp6] luteinizing hormone-releasing hormone in rhesus monkeys.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980055-1

7 January 2021

Effect of an LHRH agonist on pituitary and testicular function in rhesus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980055-1

7 January 2021

Hormonal effects of GnRH agonist in the human male: an approach to male contraception using combined androgen and GnRH agonist treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980055-1

7 January 2021

Relative binding affinities of testosterone, 19-nortestosterone and their 5 alpha-reduced derivatives to the androgen receptor and to other androgen-binding proteins: a suggested role of 5 alpha-reductive steroid metabolism in the dissociation of "m

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980055-1

7 January 2021

Use of low-dosage oral cyproterone acetate as a male contraceptive.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980055-1

7 January 2021

Reversible inhibition of testicular function by a gonadotropin hormone-releasing hormone antagonist in monkeys (Macaca fascicularis)

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980055-1

7 January 2021

New injectable testosterone ester maintains serum testosterone of castrated monkeys in the normal range for four months

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980055-1

7 January 2021

10.1016/S0950-351X(87)80055-1

Identifiers

DOI

1 reference

release_g3dbh5nqwvelxkm3mdr7ssn4lu

13 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/g3dbh5nqwvelxkm3mdr7ssn4lu

24 November 2022

mapped directly with Wikidata item

1 reference